The collection and preservation of biological material of human origin are fundamental activities for scientific research, especially in the field of genetics. A significant example is provided by the biobank of a well-known institute in Genoa, which has recently received accreditation from a recognized body, confirming its compliance with international standards.
This prestigious recognition was granted according to the UNI EN ISO 20387:2024 standard, which establishes the requirements for biobanking and shapes a framework of rules that biobanks must adhere to. With this accreditation, the facility can manage a wide range of biological materials from patients affected by genetic diseases. Among the samples processed are peripheral blood, serum, plasma, PBMC (peripheral blood mononuclear cells), urine, cerebrospinal fluid, genomic DNA, and cell lines.
This achievement is noteworthy: the Ligurian institution is only the second in Italy to receive such accreditation, which aims to ensure the systematic collection, preservation, management, and distribution of biological samples to support research and development projects. Research biobanks must guarantee the rigorous management of materials and clinical data to ensure the reproducibility and comparability of scientific results. This need is essential and requires that every phase of the process—from collection to transport, preservation to traceability and distribution—is carried out with the utmost attention and compliance with standards.
Accreditation under the UNI ISO 20387:2019 standard not only offers an international framework but also aims to establish general requirements for competence and impartiality. These requirements ensure the consistent functioning of facilities and strengthen trust in the handling of samples, which is essential for researchers and the entire scientific community.
The positioning of this biobank, which has successfully obtained such accreditation, fits within a context of growth both nationally and internationally. The importance of research in this field has never been more evident, significantly contributing to the development of new biotechnologies and innovations that can positively impact the lives of millions of people.
Biotechnology, in particular, is an emerging sector that, according to recent estimates, is expected to play an increasingly significant role in the global economy. Projections indicate that by 2030, this sector could contribute 2.7% of the global GDP, demonstrating the strategic importance of investing in research and the development of new innovative solutions that improve human health and well-being.
It is therefore clear that investing in quality biobanks and rigorous research projects not only fosters scientific progress but also translates into an economic advantage for the country’s system. The ability to collect and preserve biological samples in a standardized and professionally managed manner offers scientists valuable tools to better understand genetic diseases and develop innovative therapies.
In a world facing increasingly complex health challenges, the role of biobanks as centers for collecting vital information is more crucial than ever. They serve as pillars of scientific research, providing the necessary data and materials for pioneering investigations.
All those interested in the world of scientific research and biotechnological innovation are invited to stay updated on the latest news and discoveries coming from initiatives such as this biobank. It is through knowledge and communication that we can better understand the value of such resources and their potential impact on society.
To receive updates and learn more about the latest developments in research and biobanking, we invite you to follow our social media profiles. Your participation and interest are essential to promote the dissemination of science and biotechnology and to support the progress towards a better future.
